Conventional and wavefront-guided myopic LASIK retreatment

George J C Jin, Kevin Merkley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

• PURPOSE: To assess the clinical outcomes of conventional and wavefront-guided myopic laser in situ keratomileusis (LASIK) retreatment. • DESIGN: Retrospective, nonrandomized case series. • METHODS: The study comprised a cohort of 97 eyes having LASIK retreatment for residual myopia after primary LASIK. The eyes were divided into two groups: conventional retreatment (CR) group (n = 74) and wavefront-guided retreatment (WR) group (n = 23). The retreatment LASIK was performed using LADARVison 4000 with/without CustomCornea (Alcon Surgical, Orlando, Florida, USA). The mean follow-up was 8.9 ± 5.8 months after retreatment (range three to thirty-six months). • RESULTS: The mean pre-retreatment spherical equivalent (SE) was -0.93 ± 0.41 diopters in the CR group and -0.84 ± 0.48 diopters in the WR group (P = .409). At the last visit, the mean SE was -0.19 ± 0.28 diopters and +0.32 ± 0.47 diopters, respectively (P < .001). An SE of ± 0.50 diopters was achieved in 92% (68 of 74) of CR eyes and 65% (15 of 23) of WR eyes. In the CR group, 85% eyes had a uncorrected visual acuity (UCVA) < 20/20 and 99% < 20/40, and in the WR group, 35% and 100%, respectively. None of the CR eyes and 17% (4 of 23) of WR eyes lost two lines of best spectacle-corrected visual acuity (BSCVA). Nine percent (7 of 74) of CR eyes and 30% of WR eyes (7 of 23) had optical symptoms before retreatment, the number was reduced to 1% (1 of 74) and 4% (1 of 23), respectively. • CONCLUSIONS: In the study period with the current equipment, our results showed that conventional LASIK retreatment was superior to wavefront-guided LASIK retreatment in both efficacy and safety.

Original languageEnglish (US)
JournalAmerican Journal of Ophthalmology
Volume141
Issue number4
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Laser In Situ Keratomileusis
Retreatment
Visual Acuity

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Conventional and wavefront-guided myopic LASIK retreatment. / Jin, George J C; Merkley, Kevin.

In: American Journal of Ophthalmology, Vol. 141, No. 4, 04.2006.

Research output: Contribution to journalArticle

@article{b9dbd5a0b01a4fe39e878e43a46aa75b,
title = "Conventional and wavefront-guided myopic LASIK retreatment",
abstract = "• PURPOSE: To assess the clinical outcomes of conventional and wavefront-guided myopic laser in situ keratomileusis (LASIK) retreatment. • DESIGN: Retrospective, nonrandomized case series. • METHODS: The study comprised a cohort of 97 eyes having LASIK retreatment for residual myopia after primary LASIK. The eyes were divided into two groups: conventional retreatment (CR) group (n = 74) and wavefront-guided retreatment (WR) group (n = 23). The retreatment LASIK was performed using LADARVison 4000 with/without CustomCornea (Alcon Surgical, Orlando, Florida, USA). The mean follow-up was 8.9 ± 5.8 months after retreatment (range three to thirty-six months). • RESULTS: The mean pre-retreatment spherical equivalent (SE) was -0.93 ± 0.41 diopters in the CR group and -0.84 ± 0.48 diopters in the WR group (P = .409). At the last visit, the mean SE was -0.19 ± 0.28 diopters and +0.32 ± 0.47 diopters, respectively (P < .001). An SE of ± 0.50 diopters was achieved in 92{\%} (68 of 74) of CR eyes and 65{\%} (15 of 23) of WR eyes. In the CR group, 85{\%} eyes had a uncorrected visual acuity (UCVA) < 20/20 and 99{\%} < 20/40, and in the WR group, 35{\%} and 100{\%}, respectively. None of the CR eyes and 17{\%} (4 of 23) of WR eyes lost two lines of best spectacle-corrected visual acuity (BSCVA). Nine percent (7 of 74) of CR eyes and 30{\%} of WR eyes (7 of 23) had optical symptoms before retreatment, the number was reduced to 1{\%} (1 of 74) and 4{\%} (1 of 23), respectively. • CONCLUSIONS: In the study period with the current equipment, our results showed that conventional LASIK retreatment was superior to wavefront-guided LASIK retreatment in both efficacy and safety.",
author = "Jin, {George J C} and Kevin Merkley",
year = "2006",
month = "4",
doi = "10.1016/j.ajo.2005.11.011",
language = "English (US)",
volume = "141",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Conventional and wavefront-guided myopic LASIK retreatment

AU - Jin, George J C

AU - Merkley, Kevin

PY - 2006/4

Y1 - 2006/4

N2 - • PURPOSE: To assess the clinical outcomes of conventional and wavefront-guided myopic laser in situ keratomileusis (LASIK) retreatment. • DESIGN: Retrospective, nonrandomized case series. • METHODS: The study comprised a cohort of 97 eyes having LASIK retreatment for residual myopia after primary LASIK. The eyes were divided into two groups: conventional retreatment (CR) group (n = 74) and wavefront-guided retreatment (WR) group (n = 23). The retreatment LASIK was performed using LADARVison 4000 with/without CustomCornea (Alcon Surgical, Orlando, Florida, USA). The mean follow-up was 8.9 ± 5.8 months after retreatment (range three to thirty-six months). • RESULTS: The mean pre-retreatment spherical equivalent (SE) was -0.93 ± 0.41 diopters in the CR group and -0.84 ± 0.48 diopters in the WR group (P = .409). At the last visit, the mean SE was -0.19 ± 0.28 diopters and +0.32 ± 0.47 diopters, respectively (P < .001). An SE of ± 0.50 diopters was achieved in 92% (68 of 74) of CR eyes and 65% (15 of 23) of WR eyes. In the CR group, 85% eyes had a uncorrected visual acuity (UCVA) < 20/20 and 99% < 20/40, and in the WR group, 35% and 100%, respectively. None of the CR eyes and 17% (4 of 23) of WR eyes lost two lines of best spectacle-corrected visual acuity (BSCVA). Nine percent (7 of 74) of CR eyes and 30% of WR eyes (7 of 23) had optical symptoms before retreatment, the number was reduced to 1% (1 of 74) and 4% (1 of 23), respectively. • CONCLUSIONS: In the study period with the current equipment, our results showed that conventional LASIK retreatment was superior to wavefront-guided LASIK retreatment in both efficacy and safety.

AB - • PURPOSE: To assess the clinical outcomes of conventional and wavefront-guided myopic laser in situ keratomileusis (LASIK) retreatment. • DESIGN: Retrospective, nonrandomized case series. • METHODS: The study comprised a cohort of 97 eyes having LASIK retreatment for residual myopia after primary LASIK. The eyes were divided into two groups: conventional retreatment (CR) group (n = 74) and wavefront-guided retreatment (WR) group (n = 23). The retreatment LASIK was performed using LADARVison 4000 with/without CustomCornea (Alcon Surgical, Orlando, Florida, USA). The mean follow-up was 8.9 ± 5.8 months after retreatment (range three to thirty-six months). • RESULTS: The mean pre-retreatment spherical equivalent (SE) was -0.93 ± 0.41 diopters in the CR group and -0.84 ± 0.48 diopters in the WR group (P = .409). At the last visit, the mean SE was -0.19 ± 0.28 diopters and +0.32 ± 0.47 diopters, respectively (P < .001). An SE of ± 0.50 diopters was achieved in 92% (68 of 74) of CR eyes and 65% (15 of 23) of WR eyes. In the CR group, 85% eyes had a uncorrected visual acuity (UCVA) < 20/20 and 99% < 20/40, and in the WR group, 35% and 100%, respectively. None of the CR eyes and 17% (4 of 23) of WR eyes lost two lines of best spectacle-corrected visual acuity (BSCVA). Nine percent (7 of 74) of CR eyes and 30% of WR eyes (7 of 23) had optical symptoms before retreatment, the number was reduced to 1% (1 of 74) and 4% (1 of 23), respectively. • CONCLUSIONS: In the study period with the current equipment, our results showed that conventional LASIK retreatment was superior to wavefront-guided LASIK retreatment in both efficacy and safety.

UR - http://www.scopus.com/inward/record.url?scp=33645304893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645304893&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2005.11.011

DO - 10.1016/j.ajo.2005.11.011

M3 - Article

VL - 141

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 4

ER -